EBS - Emergent Biosolutions - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EBS is currently covered by 1 analysts with an average price target of $22.22. This is a potential upside of $10.27 (85.94%) from yesterday's end of day stock price of $11.95.

Emergent Biosolutions's activity chart (see below) currently has 101 price targets and 80 ratings on display. The stock rating distribution of EBS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 69.17% with an average time for these price targets to be met of 106 days.

Highest price target for EBS is $15, Lowest price target is $15, average price target is $15.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 16-Dec-2025. First documented stock forecast 27-Sep-2017.

Currently out of the existing stock ratings of EBS, 6 are a BUY (100%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 30-Dec-2024

$15

$4.01 (36.49%)

$15

1 months 7 days ago
(16-Dec-2025)

0/8 (0%)

$2.67 (21.65%)

Buy

Since 07-Mar-2024

$12

$1.01 (9.19%)

$8

1 years 2 months 16 days ago
(07-Nov-2024)

8/11 (72.73%)

$1 (9.09%)

65

Buy

Since 13-Sep-2024

$16

$5.01 (45.59%)

$23

1 years 4 months 10 days ago
(13-Sep-2024)

10/14 (71.43%)

$8.13 (103.30%)

134

Sell

Since 17-Mar-2023

$9

2 years 2 months 3 days ago
(20-Nov-2023)

2/3 (66.67%)

$0.88 (10.84%)

7

Hold

Since 02-Oct-2018

$15

$4.01 (36.49%)

$29

2 years 8 months 4 days ago
(19-May-2023)

4/8 (50%)

$6.83 (83.60%)

86

Show more analysts

Please expand the browser size to see the chart

What is EBS (Emergent Biosolutions) average time for price targets to be met?

On average it took 106 days on average for the stock forecasts to be realized with a an average price target met ratio 69.17

Which analyst has the current highest performing score on EBS (Emergent Biosolutions) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?

Francois Brisebois works at LIFESCI and has 9 price targets and 5 ratings on EBS

Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?

Dana Flanders with highest potential upside - $90.01

Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?

David Maris with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?